Announcement for the Company’s 2024 list of newly elected directors.
Published: 2024-05-21
| No | 2 | Date of announcement | 2024/05/21 | Time of announcement |
16:00:12 |
||||
|---|---|---|---|---|---|---|---|---|---|
| Subject |
Announcement for the Company’s 2024 list of newly elected directors. |
||||||||
| Date of events | 2024/05/21 | To which item it meets | paragraph 6 | ||||||
|
1.Date of occurrence of the change:2024/05/21 2.Elected or changed position (Please enter institutional director, institutional supervisor, independent director, natural-person director or natural-person supervisor): institutional director, independent director, natural-person director 3.Title and name of the previous position holder: (1)natural-person director:Kung-Ming Lu (2)natural-person director:Tsu-Der Lee (3)institutional director:Oneness Biotech Co., Ltd. Representative:Tu-Mu Kuo (4)institutional director:Fubon Financial Holding Venture Capital Co., Ltd,Representative:Jung-Yi Huang (5)institutional director:Taishin Venture Capital Investment Co., Ltd. Representative:Yu-Sheng Lin (6)institutional director:Microbio Co., Ltd. Representative:Wan-Jun Chen (7)independent director:Te-Tsai Li (8)independent director:Hung-Wen Lin (9)independent director:Wan-Chin Chen 4.Resume of the previous position holder: (1)natural-person director:Kung-Ming Lu Chairman, Diamond Biofund Inc. (2)natural-person director:Tsu-Der Lee Director, Taipei Medical University (3)institutional director:Oneness Biotech Co., Ltd. Representative:Tu-Mu Kuo Independent Director of Taiwan Cooperative Bank (4)institutional director:Fubon Financial Holding Venture Capital Co., Ltd,Representative:Jung-Yi Huang Senior Manager, Fubon Financial Holding Venture Capital Co., Ltd. (5)institutional director:Taishin Venture Capital Investment Co., Ltd. Representative:Yu-Sheng Lin President, Taishin Venture Capital Investment Co., Ltd. (6)institutional director:Microbio Co., Ltd. Representative:Wan-Jun Chen Vice President and Spokesperson, Microbio Co., Ltd. (7)independent director:Te-Tsai Li Distinguished Visiting Chair of Research Center for Information Technology Innovation, Academia Sinica (8)independent director:Hung-Wen Lin Consultant, Business Today (9)independent director:Wan-Chin Chen Independent Director of ABICO Netcom Co., Ltd. 5.Title and name of the new position holder: (1)institutional director:Oneness Biotech Co., Ltd. Representative:Pan-Chih Yang (2)institutional director:Oneness Biotech Co., Ltd. Representative:Tsu-Der Lee (3)natural-person director:Che-An Chou (4)independent director:Te-Tsai Li (5)independent director:Fei-Peng Li (6)independent director:Shu-Hui Chang (7)independent director:Li-Ching Chen (8)independent director:Chi-Yu Hsiang (9)independent director:Shih-Tsung Chang 6.Resume of the new position holder: (1)institutional director:Oneness Biotech Co., Ltd. Representative:Pan-Chih Yang Director, Healthcare System Administration Center, National Taiwan University Hospital (2)institutional director:Oneness Biotech Co., Ltd. Representative:Tsu-Der Lee Director, Taipei Medical University (3)natural-person director:Che-An Chou Head of biomedical investment, Ultimate Epoch Ltd. (4)independent director:Te-Tsai Li Distinguished Visiting Chair of Research Center for Information Technology Innovation, Academia Sinica (5)independent director:Fei-Peng Li Chairman, Taiwan Hospital Association (6)independent director:Shu-Hui Chang Chief Auditor, Internal Audit Office, Taipei Exchange (7)independent director:Li-Ching Chen Manager of the Strategy & International Relations Department, Taipei Exchange (8)independent director:Chi-Yu Hsiang Deputy team leader of the Market Surveillance Department, Taiwan Stock Exchange (9)independent director:Shih-Tsung Chang Director of Shen Ta United Accountants 7.Circumstances of change (Please enter “resignation”, “dismissal”,“term expired”, “death” or “new appointment”): comprehensive early reelection 8.Reason for the change: In accordance with the official letter No.1121802934 by Taiwan Stock Exchange Corporation issued on 2023/06/29.The Company has to elect Independent Directors over two-thirds of the total number of Directors in the 2024 annual Shareholders’ Meeting.The term of the fifth Board of Directors of the Company expires on June 26, 2025. To fulfill the commitments related to the listing, the Company conducted a comprehensive early reelection. 9.Number of shares held by the new position holder when elected: (1)institutional director:Oneness Biotech Co., Ltd.:119,400,289 shares Representative:Pan-Chih Yang:0 shares (2)institutional director:Oneness Biotech Co., Ltd.:119,400,289 shares Representative:Tsu-Der Lee:0 shares (3)natural-person director:Che-An Chou:0 shares (4)independent director:Te-Tsai Li:0 shares (5)independent director:Fei-Peng Li:0 shares (6)independent director:Shu-Hui Chang:17,493 shares (7)independent director:Li-Ching Chen:0 shares (8)independent director:Chi-Yu Hsiang:0 shares (9)independent director:Shih-Tsung Chang:0 shares 10.Original term (from __________ to __________):2022/06/27~2025/06/26 11.Effective date of the new appointment:2024/08/01~2027/07/31 12.Turnover rate of directors of the same term:N/A 13.Turnover rate of independent directors of the same term:N/A 14.Turnover rate of supervisors of the same term:N/A 15.Change in one-third or more of directors (Please enter “Yes” or “No”):Yes 16.Any other matters that need to be specified (the information disclosure also meets the requirements of Article 7, subparagraph 6 of the Securities and Exchange Act Enforcement Rules, which brings forth a significant impact on shareholders rights or the price of the securities on public companies.): None |
|||||||||